Abstract
In the present study an electrochemical system based on recombinant cytochrome P450 3A4 (CYP3A4) has been developed for analysis of potential drug-drug interactions between drugs prescribed for Helicobacter pylori eradication therapy. The drug-drug interaction between omeprazole (a proton pump inhibitor; PPI) and macrolide antibiotic erythromycin induced by cytochrome P450 3A4 was demonstrated. In the presence of omeprazole, the rate of erythromycin N-demethylation by CYP3A4, measured by the reaction product (formaldehyde) formation, decreased, while erythromycin had no effect on omeprazole metabolism evaluated using mass-spectrometry analysis of omeprazole sulfone as a metabolite formed during CYP3A4-dependent metabolism. These drug-drug interactions may be explained by a higher affinity of CYP3A4 for omeprazole (the spectral dissociation constant Kd = 18 ± 2 µM) than that for erythromycin (Kd = 52 µM). Using the developed model system, it is possible to analyze drug-drug interactions induced by cytochrome P450 3A4. The results obtained by means of in vitro experiments well correspond to the results of in silico modeling performed using the PASS program and PoSMNA descriptors, which also showed the possibility of drug-drug interactions between omeprazole and erythromycin at the level of biotransformation carried out by cytochrome P450 3A4.
Similar content being viewed by others
REFERENCES
Ierardi, E., Goni, E., Losurdo, G., and Di Mario, F., Helicobacter, 2014, vol. 19, suppl. 1, pp. 27−31. https://doi.org/10.1111/hel.12157
Marshall, B.J., J. Gastroenterol. Hepatol., 1991, vol. 6, pp. 121−124. https://doi.org/10.1111/j.1440-1746.1991.tb01450.x
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., and Lewis, K., FEMS Microbiol. Lett., 2004, vol. 230, pp. 13−18. https://doi.org/10.1016/S0378-1097(03)00856-5
Graham, D.Y. and Shiotani, A., Nat. Clin. Pract. Gastroenterol. Hepatol., 2008, vol. 5, pp. 321−331. https://doi.org/10.1038/ncpgasthep1138
Mizoguchi, H., Fujioka, T., and Nasu, M., J. Gastroenterol., 1999, vol. 34, suppl. 11, pp. 32−36.
Reshetnyak, V.I. and Reshetnyak, T.M., World J. Gastroenterol., 2017, vol. 23, pp. 4867−4878. https://doi.org/10.3748/wjg.v23.i27.4867
Graham, D.Y. and Fischbach, L., Gut, 2010, vol. 59, pp. 1143−1153. https://doi.org/10.1136/gut.2009.192757
Scott, D., Weeks, D., Melchers, K., and Sachs, G., Gut, 1998, vol. 43, suppl. 1, pp. S56−S60. https://doi.org/10.1136/gut.43.2008.S56
de Francesco, V., Zullo, A., Perna, F., Giorgio, F., Hassan, C., Vannella, L., Cristofari, F., Panella, C., Vaira, D., and Ierardi, E., J. Med. Microbiol., 2010, vol. 59, pp. 588−591. https://doi.org/10.1099/jmm.0.018077-0
Maconi, G., Parente, F., Russo, A., Vago, L., Im-besi, V., and Bianchi Porro, G., Am. J. Gastroenterol., 2001, vol. 96, pp. 359−366. https://doi.org/10.1111/j.1572-0241.2001.03519.x
Markham, A. and McTavish, D., Drugs, 1996, vol. 51, no. 1, pp. 161–178. https://doi.org/10.2165/00003495-199651010-00010
Attia, T.Z., Yamashita, T., Tsujino, H., Derayea, S.M., Tsutsumi, Y., and Uno, T., Chem. Pharmacol. Bull., 2019, vol. 67, no. 8, pp. 810–815. https://doi.org/10.1248/cpb.c19-00084
Calabresi, L., Pazzucconi, F., Ferrara, S., di Paolo, A., del Tacca, M., and Sirtori, C., Pharmacol. Res., 2004, vol. 49, pp. 493–499. https://doi.org/10.1016/j.phrs.2003.10.010
Cytochrome P450 Structure, Mechanism, and Biochemistry, Ortiz de Montellano, P.R., Ed., New York: Springer, 2015. https://doi.org/10.1007/978-3-319-12108-6
Guengerich, F.P., in Cytochrome P450: Structure, Mechanism, and Biochemistry, Ortiz de Montel-lano, P.R., Ed., New York: Springer, 2015, pp. 523–785.
Kuzikov, A.V., Masamrekh, R.A., Archakov, A.I., Shumyantseva, V.V., Biomed. Khim. 2018, vol. 64, no. 2, pp. 149–168. https://doi.org/10.18097/PBMC20186402149
Schneider, E. and Clark, D.S., Biosens. Bioelectron., 2013, vol. 39, pp. 1–13. https://doi.org/10.1016/j.bios.2012.05.043
Krishnan, S., Curr. Opin. Electrochem., 2020, vol. 19, pp. 20–26. https://doi.org/10.1016/j.coelec.2019.09.004
Shumyantseva, V.V., Kuzikov, A.V., Masamrekh, R.A., Bulko, T.V., and Archakov, A.I., Biosens. Bioelectron., 2018, vol. 121, pp. 192–204. https://doi.org/10.1016/j.bios.2018.08.040
Kuzikov, A.V., Masamrekh, R.A., Shkel, T., Strushkevich, N., Gilep, A., Usanov, S., Archakov, A., and Shumyantseva, V., Talanta, 2019, vol. 196, pp. 231–236. https://doi.org/10.1016/j.talanta.2018.12.041
Kuzikov, A.V., Bulko, T.V., Koroleva, P.I., Masamrekh, R.A., Babkina, S.S., Gilep, A.A., and Shumyantseva, V.V., Biomed. Khim., 2020, vol. 66, no. 1, pp. 64–70. https://doi.org/10.18097/PBMC20206601064
Lu, J., Cui, D., Li, H., Zhang, Y., and Liu, S., Electrochimica Acta, 2015, vol. 165, pp. 36–44. https://doi.org/10.1016/j.electacta.2015.02.183
Pechurskaya, T.A., Lukashevich, O.P., Gilep, A.A., and Usanov, S.A., Biochemistry (Moscow), 2008, vol. 73, pp. 806–811. https://doi.org/10.1134/S0006297908070092
Omura, T. and Sato, R., J. Biol. Chem., 1964, vol. 239, pp. 2379–2385.
Masamrekh, R.A., Kuzikov, A.V., Haurychenka, Y.I., Shcherbakov, K.A., Veselovsky, A.V., Filimonov, D.A., Dmitriev, A.V., Zavialova, M.G., Gilep, A.A., Shkel, T.V., Strushkevich, N.V., Usanov, S.A., Archakov, A.I., and Shumyantseva, V.V., Fundamental Clinical Pharmacol., 2020, vol. 34, pp. 120–130. https://doi.org/10.1111/fcp.12497
Nash, T., Biochem. J., 1953, vol. 55, pp. 416–421. https://doi.org/10.1042/bj0550416
Dmitriev, A.V., Filimonov, D.A., Rudik, A.V., Pogodin, P.V., Karasev, D.A., Lagunin, A.A., and Poroikov, V.V., SAR QSAR Environ. Res., 2019, vol. 30, pp. 1–10. https://doi.org/10.1080/1062936X.2019.1653966
Dmitriev, A., Filimonov, D., Lagunin, A., Karasev, D., Pogodin, P., Rudik, A., and Poroikov, V., Molecules, 2019, vol. 24, no. 21, pp. 3955–3962. https://doi.org/10.3390/molecules24213955
Hansten, P.D. and Horn, J.R., The Top 100 Drug Interactions 2010: A Guide to Patient Management, H&H Publications, 2010.
Shumyantseva, V.V., Makhova, A.A., Shich, E.V., Bulko, T.V., Kuzikov, A.V., Masamrekh, R.A., Shkel, T., Usanov, S.A., Gilep, A.A., and Archa-kov, A.I., BioNanoScience, 2019, vol. 9, pp. 79–86. https://doi.org/10.1007/s12668-018-0567-7
Denisov, I.G., Frank, D.J., and Sligar, S.G., Pharmacology & Therapeutics, 2009, vol. 124, no. 2, pp. 151–167. https://doi.org/10.1016/j.pharmthera.2009.05.011
Sadeghi, S.J., Ferrero, S., di Nardo, G., and Gilardi, G., Bioelectrochemistry, 2012, vol. 86, pp. 87–91. https://doi.org/10.1016/j.bioelechem.2012.02.010
Masamrekh, R., Kuzikov, A., Veselovsky, A., Toropygin, I., Shkel, T., Strushkevich, N., Gilep, A., Usanov, S., Archakov, A., and Shumyantseva, V., J. Inorg. Biochem., 2018, vol. 186, pp. 24–33. https://doi.org/10.1016/j.jinorgbio.2018.05.010
Korzekwa, K.R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R.A., Rettie, A.E., Gonzalez, F.J., and Tracey, T.S., Biochemistry, 1998, vol. 37, pp. 4137–4147. https://doi.org/10.1021/bi9715627
Shou, M., Dai, R., Korzekwa, K.R., Baillie, T.A., and Rushmore, T.H., J. Biol. Chem., 2001, vol. 276, pp. 2256–2262. https://doi.org/10.1074/jbc.M008799200
Zhao, L., Sun, N., Tian, L., Zhao, S., Sun, B., Sun, Y., and Zhao, D., Bioorganic Medicinal Chemistry Letts., 2019, vol. 29, pp. 2016–2024. https://doi.org/10.1016/j.bmcl.2019.06.040
Greenblatt, D.J., Zhao, Y., Venkatakrishnan, K., Duan, S.X., Harmatz, J.S., Parent, S.J., Court, M.H., and von Moltke, L.L., J. Pharmacy Pharmacol., 2011, vol. 63, no. 2, pp. 214–221. https://doi.org/10.1111/j.2042-7158.2010.01202.x
Lewis, D.F.V. and and Lake, B.G., Toxicology, 1998, vol. 125, pp. 31–44. https://doi.org/10.1016/S0300-483X(97)00159-5
Lutz, J.D. and Isoherranen, N., Drug Metab. Dispos., 2012, vol. 40, pp. 159–168. https://doi.org/10.1124/dmd.111.042200
McConn, D.J., Lin, Y.S., Allen, K., Kunze, K.L., and Thummel, K.E., Drug Metab. Dispos., 2004, vol. 32, pp. 1083–1091. https://doi.org/10.1124/dmd.32.10
Funding
The study was supported by the Russian Science Foundation (project no. 17-75-20250).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any research involving humans or the use of animals as objects.
CONFLICT OF INTERESTS
The authors declare that they have no conflict of interests.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Koroleva, P.I., Kuzikov, A.V., Masamrekh, R.A. et al. Modeling of Drug-Drug Interactions between Omeprazole and Erythromycin in the Cytochrome P450-Dependent System In vitro. Biochem. Moscow Suppl. Ser. B 15, 62–70 (2021). https://doi.org/10.1134/S1990750821010030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821010030